RHON-KLINIKUM AG Unsponsored ADR(RKAGY)

Research Snapshot

RHON-KLINIKUM AG Unsponsored ADR (RKAGY) is a Healthcare stock with a market cap of $830.00M and listed on OTC. The stock last traded around $8.16 and up 6.7% across the available one-year price window (Jun 20, 2025 → Jun 11, 2026). Baseline metrics include revenue growth of +16.5%, EPS growth of -26.9%, a dividend yield of 0.8%. What stands out right now is revenue +16.5%, EPS -26.9%, free cash flow -158.1% with operating margin 2.4% and ROIC 2.2%. The dividend is present but secondary, with a yield around 0.8%. Valuation is more restrained than many high-expectation growth names at P/E 24.1 and price/sales 0.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RKAGY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.